Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Novartis taps Bernstein’s Gal for new C-level strategy and growth position

Former analyst will ‘prioritize the portfolio’ as pharma sharpens focus on higher-value launches

April 26, 2022 3:00 PM UTC

Weeks after Novartis CEO Vas Narasimhan stressed the need for a new C-level officer to set priorities around R&D and deal-making decisions, the pharma company has named Sanford Bernstein analyst Ronny Gal to fill the position.

Effective by Aug. 1, Gal will become the first chief strategy and growth officer at Novartis AG (SIX:NOVN; NYSE:NVS). On an April 4 conference call, Narasimhan said the company was seeking someone to work alongside R&D to “prioritize the portfolio in an independent way,” with an eye toward “high-value” products with at least $2 billion in potential peak sales. Novartis has identified about 20 pipeline candidates in that category, but could also make deals...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Novartis AG